These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 26732039)
1. Considering GH replacement for GH-deficient adults with a previous history of cancer: a conundrum for the clinician. Yuen KC; Heaney AP; Popovic V Endocrine; 2016 May; 52(2):194-205. PubMed ID: 26732039 [TBL] [Abstract][Full Text] [Related]
2. Growth hormone replacement in patients with a history of malignancy: a review of the literature and best practice for offering treatment. Yuen KC; Popovic V Expert Rev Endocrinol Metab; 2015 May; 10(3):319-326. PubMed ID: 30298774 [TBL] [Abstract][Full Text] [Related]
3. Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database). Popovic V; Mattsson AF; Gaillard RC; Wilton P; Koltowska-Häggström M; Ranke MB J Clin Endocrinol Metab; 2010 Sep; 95(9):4449-54. PubMed ID: 20610598 [TBL] [Abstract][Full Text] [Related]
4. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults. van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML Pituitary; 2016 Aug; 19(4):381-90. PubMed ID: 27048484 [TBL] [Abstract][Full Text] [Related]
5. Controversies in the risk of neoplasia in GH deficiency. Pekic S; Stojanovic M; Popovic V Best Pract Res Clin Endocrinol Metab; 2017 Feb; 31(1):35-47. PubMed ID: 28477731 [TBL] [Abstract][Full Text] [Related]
13. Cancer risk following growth hormone use in childhood: implications for current practice. Ogilvy-Stuart AL; Gleeson H Drug Saf; 2004; 27(6):369-82. PubMed ID: 15144231 [TBL] [Abstract][Full Text] [Related]
14. Tumor Recurrence or Regrowth in Adults With Nonfunctioning Pituitary Adenomas Using GH Replacement Therapy. van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML J Clin Endocrinol Metab; 2015 Aug; 100(8):3132-9. PubMed ID: 26057181 [TBL] [Abstract][Full Text] [Related]
15. GH therapy and cancer risk in hypopituitarism: what we know from human studies. Pekic S; Popovic V Eur J Endocrinol; 2013 Nov; 169(5):R89-97. PubMed ID: 23935131 [TBL] [Abstract][Full Text] [Related]
16. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement. Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440 [TBL] [Abstract][Full Text] [Related]
17. Treatment with Growth Hormone for Adults with Growth Hormone Deficiency Syndrome: Benefits and Risks. Díez JJ; Sangiao-Alvarellos S; Cordido F Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562611 [TBL] [Abstract][Full Text] [Related]